| Year |
Citation |
Score |
| 2024 |
Reba SM, Li Q, Onwuzulike S, Nagy N, Fletcher S, Parker K, Shaw RJ, Umphred-Wilson K, Shukla S, Harding CV, Boom WH, Rojas RE. TLR2 on CD4+ and CD8+ T cells promotes control of Mycobacterium tuberculosis infection. European Journal of Immunology. e2350715. PMID 38446066 DOI: 10.1002/eji.202350715 |
0.337 |
|
| 2023 |
Mwebaza I, Shaw R, Li Q, Fletcher S, Achkar JM, Harding CV, Carpenter SM, Boom WH. Impact of Mycobacterium tuberculosis Glycolipids on the CD4+ T Cell-Macrophage Immunological Synapse. Journal of Immunology (Baltimore, Md. : 1950). PMID 37695687 DOI: 10.4049/jimmunol.2300107 |
0.347 |
|
| 2018 |
Shukla S, Richardson ET, Drage MG, Boom WH, Harding CV. lipoprotein and lipoglycan binding to Toll-like receptor 2 correlates with agonist activity and functional outcomes. Infection and Immunity. PMID 30037791 DOI: 10.1128/Iai.00450-18 |
0.338 |
|
| 2017 |
Karim AF, Sande OJ, Tomeckho SE, Ding X, Li M, Maxwell S, Ewing RM, Harding CV, Rojas RE, Chance MR, Boom WH. Proteomics and Network Analyses Reveal Inhibition of Akt-mTOR Signaling in CD4(+) T Cells by Mycobacterium Tuberculosis Mannose-Capped Lipoarabinomannan. Proteomics. PMID 28994205 DOI: 10.1002/Pmic.201700233 |
0.4 |
|
| 2017 |
Athman JJ, Sande OJ, Groft SG, Reba SM, Nagy N, Wearsch PA, Richardson ET, Rojas R, Boom WH, Shukla S, Harding CV. Mycobacterium tuberculosis Membrane Vesicles Inhibit T Cell Activation. Journal of Immunology (Baltimore, Md. : 1950). PMID 28122965 DOI: 10.4049/Jimmunol.1601199 |
0.457 |
|
| 2016 |
Nguyen TP, Shukla S, Asaad R, Freeman ML, Lederman MM, Harding CV, Sieg SF. Responsiveness to IL-7 but not to IFN-α is diminished in CD4 T cells from treated HIV infected patients who experience poor CD4 T cell recovery. Aids (London, England). PMID 27191978 DOI: 10.1097/Qad.0000000000001161 |
0.379 |
|
| 2016 |
Schorey JS, Harding CV. Extracellular vesicles and infectious diseases: new complexity to an old story. The Journal of Clinical Investigation. 126: 1181-9. PMID 27035809 DOI: 10.1172/Jci81132 |
0.374 |
|
| 2015 |
Sande OJ, Karim AF, Li Q, Ding X, Harding CV, Rojas RE, Boom WH. Mannose-Capped Lipoarabinomannan from Mycobacterium tuberculosis Induces CD4+ T Cell Anergy via GRAIL. Journal of Immunology (Baltimore, Md. : 1950). PMID 26667170 DOI: 10.4049/Jimmunol.1500710 |
0.443 |
|
| 2015 |
Shameli A, Xiao W, Zheng Y, Shyu S, Sumodi J, Meyerson HJ, Harding CV, Maitta RW. A critical role for alpha-synuclein in development and function of T lymphocytes. Immunobiology. PMID 26517968 DOI: 10.1016/J.Imbio.2015.10.002 |
0.377 |
|
| 2015 |
Richardson ET, Shukla S, Nagy N, Boom WH, Beck RC, Zhou L, Landreth GE, Harding CV. ERK Signaling Is Essential for Macrophage Development. Plos One. 10: e0140064. PMID 26445168 DOI: 10.1371/Journal.Pone.0140064 |
0.331 |
|
| 2015 |
Athman JJ, Wang Y, McDonald DJ, Boom WH, Harding CV, Wearsch PA. Bacterial Membrane Vesicles Mediate the Release of Mycobacterium tuberculosis Lipoglycans and Lipoproteins from Infected Macrophages. Journal of Immunology (Baltimore, Md. : 1950). PMID 26109643 DOI: 10.4049/Jimmunol.1402894 |
0.406 |
|
| 2015 |
Nguyen TP, Bazdar DA, Mudd JC, Lederman MM, Harding CV, Hardy GA, Sieg SF. Interferon-α inhibits CD4 T cell responses to interleukin-7 and interleukin-2 and selectively interferes with Akt signaling. Journal of Leukocyte Biology. 97: 1139-46. PMID 25784743 DOI: 10.1189/Jlb.4A0714-345Rr |
0.348 |
|
| 2015 |
Richardson ET, Shukla S, Sweet DR, Wearsch PA, Tsichlis PN, Boom WH, Harding CV. Toll-like receptor 2-dependent extracellular signal-regulated kinase signaling in Mycobacterium tuberculosis-infected macrophages drives anti-inflammatory responses and inhibits Th1 polarization of responding T cells. Infection and Immunity. 83: 2242-54. PMID 25776754 DOI: 10.1128/Iai.00135-15 |
0.454 |
|
| 2014 |
Shukla S, Richardson ET, Athman JJ, Shi L, Wearsch PA, McDonald D, Banaei N, Boom WH, Jackson M, Harding CV. Mycobacterium tuberculosis lipoprotein LprG binds lipoarabinomannan and determines its cell envelope localization to control phagolysosomal fusion. Plos Pathogens. 10: e1004471. PMID 25356793 DOI: 10.1371/Journal.Ppat.1004471 |
0.399 |
|
| 2014 |
Xiao W, Shameli A, Harding CV, Meyerson HJ, Maitta RW. Late stages of hematopoiesis and B cell lymphopoiesis are regulated by α-synuclein, a key player in Parkinson's disease. Immunobiology. 219: 836-44. PMID 25092570 DOI: 10.1016/J.Imbio.2014.07.014 |
0.344 |
|
| 2014 |
Zhang L, Luo Z, Sieg SF, Funderburg NT, Yu X, Fu P, Wu H, Jiao Y, Gao Y, Greenspan NS, Harding CV, Kilby JM, Li Z, Lederman MM, Jiang W. Plasmacytoid dendritic cells mediate synergistic effects of HIV and lipopolysaccharide on CD27+ IgD- memory B cell apoptosis. Journal of Virology. 88: 11430-41. PMID 25056888 DOI: 10.1128/Jvi.00682-14 |
0.3 |
|
| 2014 |
Reba SM, Li Q, Onwuzulike S, Ding X, Karim AF, Hernandez Y, Fulton SA, Harding CV, Lancioni CL, Nagy N, Rodriguez ME, Wearsch PA, Rojas RE. TLR2 engagement on CD4(+) T cells enhances effector functions and protective responses to Mycobacterium tuberculosis. European Journal of Immunology. 44: 1410-21. PMID 24497180 DOI: 10.1002/Eji.201344100 |
0.475 |
|
| 2014 |
Shameli A, Zheng Y, Harding C, Meyerson H, Maitta R. Alpha-Synuclein Deficiency Is Associated with Defective Th2 Differentiation and Enhanced Regulatory T Cell Development Blood. 124: 1424-1424. DOI: 10.1182/Blood.V124.21.1424.1424 |
0.382 |
|
| 2013 |
Funderburg NT, Stubblefield Park SR, Sung HC, Hardy G, Clagett B, Ignatz-Hoover J, Harding CV, Fu P, Katz JA, Lederman MM, Levine AD. Circulating CD4(+) and CD8(+) T cells are activated in inflammatory bowel disease and are associated with plasma markers of inflammation. Immunology. 140: 87-97. PMID 23600521 DOI: 10.1111/Imm.12114 |
0.379 |
|
| 2013 |
Hardy GA, Sieg S, Rodriguez B, Anthony D, Asaad R, Jiang W, Mudd J, Schacker T, Funderburg NT, Pilch-Cooper HA, Debernardo R, Rabin RL, Lederman MM, Harding CV. Interferon-α is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers. Plos One. 8: e56527. PMID 23437155 DOI: 10.1371/Journal.Pone.0056527 |
0.355 |
|
| 2013 |
Mudd JC, Murphy P, Manion M, Debernardo R, Hardacre J, Ammori J, Hardy GA, Harding CV, Mahabaleshwar GH, Jain MK, Jacobson JM, Brooks AD, Lewis S, Schacker TW, Anderson J, et al. Impaired T-cell responses to sphingosine-1-phosphate in HIV-1 infected lymph nodes. Blood. 121: 2914-22. PMID 23422746 DOI: 10.1182/Blood-2012-07-445783 |
0.359 |
|
| 2013 |
Harding CV, Heuser JE, Stahl PD. Exosomes: looking back three decades and into the future. The Journal of Cell Biology. 200: 367-71. PMID 23420870 DOI: 10.1083/Jcb.201212113 |
0.574 |
|
| 2013 |
Shameli A, Xiao W, Harding C, Meyerson H, Sumodi J, Maitta R. Development Of Mature T Lymphocytes Requires Alpha-Synuclein Blood. 122: 3490-3490. DOI: 10.1182/Blood.V122.21.3490.3490 |
0.336 |
|
| 2012 |
Mahon RN, Sande OJ, Rojas RE, Levine AD, Harding CV, Boom WH. Mycobacterium tuberculosis ManLAM inhibits T-cell-receptor signaling by interference with ZAP-70, Lck and LAT phosphorylation. Cellular Immunology. 275: 98-105. PMID 22507872 DOI: 10.1016/J.Cellimm.2012.02.009 |
0.458 |
|
| 2012 |
Simmons DP, Wearsch PA, Canaday DH, Meyerson HJ, Liu YC, Wang Y, Boom WH, Harding CV. Type I IFN drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processing. Journal of Immunology (Baltimore, Md. : 1950). 188: 3116-26. PMID 22371391 DOI: 10.4049/Jimmunol.1101313 |
0.533 |
|
| 2012 |
Conry SJ, Meng Q, Hardy G, Yonkers NL, Sugalski JM, Hirsch A, Davitkov P, Compan A, Falck-Ytter Y, Blanton RE, Rodriguez B, Harding CV, Anthony DD. Genetically associated CD16(+)56(-) natural killer cell interferon (IFN)-αR expression regulates signaling and is implicated in IFN-α-induced hepatitis C virus decline. The Journal of Infectious Diseases. 205: 1131-41. PMID 22351942 DOI: 10.1093/Infdis/Jis027 |
0.326 |
|
| 2012 |
Manion M, Rodriguez B, Medvik K, Hardy G, Harding CV, Schooley RT, Pollard R, Asmuth D, Murphy R, Barker E, Brady KE, Landay A, Funderburg N, Sieg SF, Lederman MM. Interferon-alpha administration enhances CD8+ T cell activation in HIV infection. Plos One. 7: e30306. PMID 22291932 DOI: 10.1371/Journal.Pone.0030306 |
0.355 |
|
| 2012 |
Liu YC, Simmons DP, Li X, Abbott DW, Boom WH, Harding CV. TLR2 signaling depletes IRAK1 and inhibits induction of type I IFN by TLR7/9. Journal of Immunology (Baltimore, Md. : 1950). 188: 1019-26. PMID 22227568 DOI: 10.4049/Jimmunol.1102181 |
0.366 |
|
| 2012 |
Li Q, Ding X, Thomas JJ, Harding CV, Pecora ND, Ziady AG, Shank S, Boom WH, Lancioni CL, Rojas RE. Rv2468c, a novel Mycobacterium tuberculosis protein that costimulates human CD4+ T cells through VLA-5. Journal of Leukocyte Biology. 91: 311-20. PMID 22158781 DOI: 10.1189/Jlb.0711364 |
0.462 |
|
| 2011 |
Jiang W, Lederman MM, Harding CV, Sieg SF. Presentation of soluble antigens to CD8+ T cells by CpG oligodeoxynucleotide-primed human naive B cells. Journal of Immunology (Baltimore, Md. : 1950). 186: 2080-6. PMID 21239717 DOI: 10.4049/Jimmunol.1001869 |
0.459 |
|
| 2011 |
Lancioni CL, Li Q, Thomas JJ, Ding X, Thiel B, Drage MG, Pecora ND, Ziady AG, Shank S, Harding CV, Boom WH, Rojas RE. Mycobacterium tuberculosis lipoproteins directly regulate human memory CD4(+) T cell activation via Toll-like receptors 1 and 2. Infection and Immunity. 79: 663-73. PMID 21078852 DOI: 10.1128/Iai.00806-10 |
0.484 |
|
| 2010 |
Ramachandra L, Qu Y, Wang Y, Lewis CJ, Cobb BA, Takatsu K, Boom WH, Dubyak GR, Harding CV. Mycobacterium tuberculosis synergizes with ATP to induce release of microvesicles and exosomes containing major histocompatibility complex class II molecules capable of antigen presentation. Infection and Immunity. 78: 5116-25. PMID 20837713 DOI: 10.1128/Iai.01089-09 |
0.523 |
|
| 2010 |
Drage MG, Tsai HC, Pecora ND, Cheng TY, Arida AR, Shukla S, Rojas RE, Seshadri C, Moody DB, Boom WH, Sacchettini JC, Harding CV. Mycobacterium tuberculosis lipoprotein LprG (Rv1411c) binds triacylated glycolipid agonists of Toll-like receptor 2. Nature Structural & Molecular Biology. 17: 1088-95. PMID 20694006 DOI: 10.1038/Nsmb.1869 |
0.349 |
|
| 2010 |
Simmons DP, Canaday DH, Liu Y, Li Q, Huang A, Boom WH, Harding CV. Mycobacterium tuberculosis and TLR2 agonists inhibit induction of type I IFN and class I MHC antigen cross processing by TLR9. Journal of Immunology (Baltimore, Md. : 1950). 185: 2405-15. PMID 20660347 DOI: 10.4049/Jimmunol.0904005 |
0.438 |
|
| 2010 |
Reuter MA, Pecora ND, Harding CV, Canaday DH, McDonald D. Mycobacterium tuberculosis promotes HIV trans-infection and suppresses major histocompatibility complex class II antigen processing by dendritic cells. Journal of Virology. 84: 8549-60. PMID 20592078 DOI: 10.1128/Jvi.02303-09 |
0.41 |
|
| 2010 |
Shin DM, Yuk JM, Lee HM, Lee SH, Son JW, Harding CV, Kim JM, Modlin RL, Jo EK. Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signalling. Cellular Microbiology. 12: 1648-65. PMID 20560977 DOI: 10.1111/J.1462-5822.2010.01497.X |
0.352 |
|
| 2010 |
Harding CV, Boom WH. Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors. Nature Reviews. Microbiology. 8: 296-307. PMID 20234378 DOI: 10.1038/Nrmicro2321 |
0.569 |
|
| 2010 |
Liu YC, Gray RC, Hardy GA, Kuchtey J, Abbott DW, Emancipator SN, Harding CV. CpG-B oligodeoxynucleotides inhibit TLR-dependent and -independent induction of type I IFN in dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 184: 3367-76. PMID 20181884 DOI: 10.4049/Jimmunol.0903079 |
0.381 |
|
| 2010 |
Harding CV, Ramachandra L. Presenting exogenous antigen to T cells. Current Protocols in Immunology / Edited by John E. Coligan ... [Et Al.]. Unit 16.2. PMID 20143316 DOI: 10.1002/0471142735.Im1602S88 |
0.426 |
|
| 2010 |
Harding CV, Canaday D, Ramachandra L. Choosing and preparing antigen-presenting cells. Current Protocols in Immunology / Edited by John E. Coligan ... [Et Al.]. Unit 16.1. PMID 20143315 DOI: 10.1002/0471142735.Im1601S88 |
0.426 |
|
| 2009 |
Mahon RN, Rojas RE, Fulton SA, Franko JL, Harding CV, Boom WH. Mycobacterium tuberculosis cell wall glycolipids directly inhibit CD4+ T-cell activation by interfering with proximal T-cell-receptor signaling. Infection and Immunity. 77: 4574-83. PMID 19651854 DOI: 10.1128/Iai.00222-09 |
0.467 |
|
| 2009 |
Drage MG, Pecora ND, Hise AG, Febbraio M, Silverstein RL, Golenbock DT, Boom WH, Harding CV. TLR2 and its co-receptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis. Cellular Immunology. 258: 29-37. PMID 19362712 DOI: 10.1016/J.Cellimm.2009.03.008 |
0.397 |
|
| 2009 |
Qu Y, Ramachandra L, Mohr S, Franchi L, Harding CV, Nunez G, Dubyak GR. P2X7 receptor-stimulated secretion of MHC class II-containing exosomes requires the ASC/NLRP3 inflammasome but is independent of caspase-1. Journal of Immunology (Baltimore, Md. : 1950). 182: 5052-62. PMID 19342685 DOI: 10.4049/Jimmunol.0802968 |
0.432 |
|
| 2009 |
Hardy GA, Sieg SF, Rodriguez B, Jiang W, Asaad R, Lederman MM, Harding CV. Desensitization to type I interferon in HIV-1 infection correlates with markers of immune activation and disease progression. Blood. 113: 5497-505. PMID 19299650 DOI: 10.1182/Blood-2008-11-190231 |
0.325 |
|
| 2009 |
Ramachandra L, Simmons D, Harding CV. MHC molecules and microbial antigen processing in phagosomes. Current Opinion in Immunology. 21: 98-104. PMID 19217269 DOI: 10.1016/J.Coi.2009.01.001 |
0.539 |
|
| 2009 |
Pecora ND, Fulton SA, Reba SM, Drage MG, Simmons DP, Urankar-Nagy NJ, Boom WH, Harding CV. Mycobacterium bovis BCG decreases MHC-II expression in vivo on murine lung macrophages and dendritic cells during aerosol infection. Cellular Immunology. 254: 94-104. PMID 18762288 DOI: 10.1016/J.Cellimm.2008.07.002 |
0.429 |
|
| 2008 |
Jiang W, Lederman MM, Mohner RJ, Rodriguez B, Nedrich TM, Harding CV, Sieg SF. Impaired naive and memory B-cell responsiveness to TLR9 stimulation in human immunodeficiency virus infection. Journal of Virology. 82: 7837-45. PMID 18524824 DOI: 10.1128/Jvi.00660-08 |
0.358 |
|
| 2008 |
Shin DM, Yang CS, Lee JY, Lee SJ, Choi HH, Lee HM, Yuk JM, Harding CV, Jo EK. Mycobacterium tuberculosis lipoprotein-induced association of TLR2 with protein kinase C zeta in lipid rafts contributes to reactive oxygen species-dependent inflammatory signalling in macrophages. Cellular Microbiology. 10: 1893-905. PMID 18503635 DOI: 10.1111/J.1462-5822.2008.01179.X |
0.345 |
|
| 2008 |
Ramachandra L, Boom WH, Harding CV. Class II MHC antigen processing in phagosomes. Methods in Molecular Biology (Clifton, N.J.). 445: 353-77. PMID 18425462 DOI: 10.1007/978-1-59745-157-4_23 |
0.555 |
|
| 2008 |
Anis MM, Fulton SA, Reba SM, Liu Y, Harding CV, Boom WH. Modulation of pulmonary dendritic cell function during mycobacterial infection. Infection and Immunity. 76: 671-7. PMID 18039834 DOI: 10.1128/Iai.01079-07 |
0.4 |
|
| 2008 |
Askew D, Harding CV. Antigen processing and CD24 expression determine antigen presentation by splenic CD4+ and CD8+ dendritic cells. Immunology. 123: 447-55. PMID 17949418 DOI: 10.1111/J.1365-2567.2007.02711.X |
0.434 |
|
| 2007 |
Funderburg N, Lederman MM, Feng Z, Drage MG, Jadlowsky J, Harding CV, Weinberg A, Sieg SF. Human -defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. Proceedings of the National Academy of Sciences of the United States of America. 104: 18631-5. PMID 18006661 DOI: 10.1073/Pnas.0702130104 |
0.44 |
|
| 2007 |
Pennini ME, Liu Y, Yang J, Croniger CM, Boom WH, Harding CV. CCAAT/enhancer-binding protein beta and delta binding to CIITA promoters is associated with the inhibition of CIITA expression in response to Mycobacterium tuberculosis 19-kDa lipoprotein. Journal of Immunology (Baltimore, Md. : 1950). 179: 6910-8. PMID 17982082 DOI: 10.4049/Jimmunol.179.10.6910 |
0.332 |
|
| 2007 |
Jiang W, Lederman MM, Harding CV, Rodriguez B, Mohner RJ, Sieg SF. TLR9 stimulation drives naïve B cells to proliferate and to attain enhanced antigen presenting function. European Journal of Immunology. 37: 2205-13. PMID 17621369 DOI: 10.1002/Eji.200636984 |
0.423 |
|
| 2007 |
Jo EK, Yang CS, Choi CH, Harding CV. Intracellular signalling cascades regulating innate immune responses to Mycobacteria: branching out from Toll-like receptors. Cellular Microbiology. 9: 1087-98. PMID 17359235 DOI: 10.1111/J.1462-5822.2007.00914.X |
0.359 |
|
| 2007 |
Anis MM, Fulton SA, Reba SM, Harding CV, Boom WH. Modulation of naive CD4+ T-cell responses to an airway antigen during pulmonary mycobacterial infection. Infection and Immunity. 75: 2260-8. PMID 17296758 DOI: 10.1128/Iai.01709-06 |
0.397 |
|
| 2007 |
Gray RC, Kuchtey J, Harding CV. CpG-B ODNs potently induce low levels of IFN-alphabeta and induce IFN-alphabeta-dependent MHC-I cross-presentation in DCs as effectively as CpG-A and CpG-C ODNs. Journal of Leukocyte Biology. 81: 1075-85. PMID 17227820 DOI: 10.1189/Jlb.1006606 |
0.429 |
|
| 2006 |
Canaday DH, Chakravarti S, Srivastava T, Tisch DJ, Cheruvu VK, Smialek J, Harding CV, Ramachandra L. Class II MHC antigen presentation defect in neonatal monocytes is not correlated with decreased MHC-II expression. Cellular Immunology. 243: 96-106. PMID 17324388 DOI: 10.1016/J.Cellimm.2007.01.003 |
0.505 |
|
| 2006 |
Rojas RE, Thomas JJ, Gehring AJ, Hill PJ, Belisle JT, Harding CV, Boom WH. Phosphatidylinositol mannoside from Mycobacterium tuberculosis binds alpha5beta1 integrin (VLA-5) on CD4+ T cells and induces adhesion to fibronectin. Journal of Immunology (Baltimore, Md. : 1950). 177: 2959-68. PMID 16920931 DOI: 10.4049/Jimmunol.177.5.2959 |
0.683 |
|
| 2006 |
Rodriguez B, Lederman MM, Jiang W, Bazdar DA, Gàrate K, Harding CV, Sieg SF. Interferon-alpha differentially rescues CD4 and CD8 T cells from apoptosis in HIV infection. Aids (London, England). 20: 1379-89. PMID 16791012 DOI: 10.1097/01.Aids.0000233571.51899.Ab |
0.336 |
|
| 2006 |
Pecora ND, Gehring AJ, Canaday DH, Boom WH, Harding CV. Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function. Journal of Immunology (Baltimore, Md. : 1950). 177: 422-9. PMID 16785538 DOI: 10.4049/Jimmunol.177.1.422 |
0.732 |
|
| 2006 |
von Delwig A, Hilkens CM, Altmann DM, Holmdahl R, Isaacs JD, Harding CV, Robertson H, McKie N, Robinson JH. Inhibition of macropinocytosis blocks antigen presentation of type II collagen in vitro and in vivo in HLA-DR1 transgenic mice. Arthritis Research & Therapy. 8: R93. PMID 16704744 DOI: 10.1186/Ar1964 |
0.5 |
|
| 2006 |
Kuchtey J, Fulton SA, Reba SM, Harding CV, Boom WH. Interferon-alphabeta mediates partial control of early pulmonary Mycobacterium bovis bacillus Calmette-Guérin infection. Immunology. 118: 39-49. PMID 16630021 DOI: 10.1111/J.1365-2567.2006.02337.X |
0.353 |
|
| 2006 |
Jung SB, Yang CS, Lee JS, Shin AR, Jung SS, Son JW, Harding CV, Kim HJ, Park JK, Paik TH, Song CH, Jo EK. The mycobacterial 38-kilodalton glycolipoprotein antigen activates the mitogen-activated protein kinase pathway and release of proinflammatory cytokines through Toll-like receptors 2 and 4 in human monocytes. Infection and Immunity. 74: 2686-96. PMID 16622205 DOI: 10.1128/Iai.74.5.2686-2696.2006 |
0.395 |
|
| 2006 |
Pennini ME, Pai RK, Schultz DC, Boom WH, Harding CV. Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-gamma-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling. Journal of Immunology (Baltimore, Md. : 1950). 176: 4323-30. PMID 16547269 DOI: 10.4049/Jimmunol.176.7.4323 |
0.606 |
|
| 2006 |
Torres M, Ramachandra L, Rojas RE, Bobadilla K, Thomas J, Canaday DH, Harding CV, Boom WH. Role of phagosomes and major histocompatibility complex class II (MHC-II) compartment in MHC-II antigen processing of Mycobacterium tuberculosis in human macrophages. Infection and Immunity. 74: 1621-30. PMID 16495533 DOI: 10.1128/Iai.74.3.1621-1630.2006 |
0.503 |
|
| 2006 |
von Delwig A, Altmann DM, Isaacs JD, Harding CV, Holmdahl R, McKie N, Robinson JH. The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse model. Arthritis and Rheumatism. 54: 482-91. PMID 16447222 DOI: 10.1002/Art.21565 |
0.487 |
|
| 2006 |
Ramachandra L, Smialek JL, Shank SS, Convery M, Boom WH, Harding CV. Erratum: Phagosomal processing of Mycobacterium tuberculosis antigen 85B is modulated independently of mycobacterial viability and phagosome maturation (Infection and Immunity (2005) 73, 2 (1097-1105)) Infection and Immunity. 74: 802-802. DOI: 10.1128/Iai.74.1.802.2006 |
0.417 |
|
| 2005 |
Von Delwig A, Musson JA, Shim HK, Lee JJ, Walker N, Harding CV, Williamson ED, Robinson JH. Distribution of productive antigen-processing activity for MHC class II presentation in macrophages Scandinavian Journal of Immunology. 62: 243-250. PMID 16179011 DOI: 10.1111/J.1365-3083.2005.01664.X |
0.502 |
|
| 2005 |
Kuchtey J, Chefalo PJ, Gray RC, Ramachandra L, Harding CV. Enhancement of dendritic cell antigen cross-presentation by CpG DNA involves type I IFN and stabilization of class I MHC mRNA. Journal of Immunology (Baltimore, Md. : 1950). 175: 2244-51. PMID 16081792 DOI: 10.4049/Jimmunol.175.4.2244 |
0.464 |
|
| 2005 |
Bagai R, Valujskikh A, Canaday DH, Bailey E, Lalli PN, Harding CV, Heeger PS. Mouse endothelial cells cross-present lymphocyte-derived antigen on class I MHC via a TAP1- and proteasome-dependent pathway. Journal of Immunology (Baltimore, Md. : 1950). 174: 7711-5. PMID 15944272 DOI: 10.4049/Jimmunol.174.12.7711 |
0.446 |
|
| 2005 |
Tobian AA, Harding CV, Canaday DH. Mycobacterium tuberculosis heat shock fusion protein enhances class I MHC cross-processing and -presentation by B lymphocytes. Journal of Immunology (Baltimore, Md. : 1950). 174: 5209-14. PMID 15843516 DOI: 10.4049/Jimmunol.174.9.5209 |
0.661 |
|
| 2005 |
Jiang W, Lederman MM, Salkowitz JR, Rodriguez B, Harding CV, Sieg SF. Impaired monocyte maturation in response to CpG oligodeoxynucleotide is related to viral RNA levels in human immunodeficiency virus disease and is at least partially mediated by deficiencies in alpha/beta interferon responsiveness and production. Journal of Virology. 79: 4109-19. PMID 15767412 DOI: 10.1128/Jvi.79.7.4109-4119.2005 |
0.338 |
|
| 2005 |
Pan Y, Chefalo P, Nagy N, Harding C, Guo Z. Synthesis and immunological properties of N-modified GM3 antigens as therapeutic cancer vaccines. Journal of Medicinal Chemistry. 48: 875-83. PMID 15689172 DOI: 10.1021/Jm0494422 |
0.317 |
|
| 2005 |
Ramachandra L, Smialek JL, Shank SS, Convery M, Boom WH, Harding CV. Phagosomal processing of Mycobacterium tuberculosis antigen 85B is modulated independently of mycobacterial viability and phagosome maturation. Infection and Immunity. 73: 1097-105. PMID 15664953 DOI: 10.1128/Iai.73.2.1097-1105.2005 |
0.432 |
|
| 2004 |
Pai RK, Pennini ME, Tobian AA, Canaday DH, Boom WH, Harding CV. Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages. Infection and Immunity. 72: 6603-14. PMID 15501793 DOI: 10.1128/Iai.72.11.6603-6614.2004 |
0.724 |
|
| 2004 |
Tobian AA, Canaday DH, Harding CV. Bacterial heat shock proteins enhance class II MHC antigen processing and presentation of chaperoned peptides to CD4+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 173: 5130-7. PMID 15470057 DOI: 10.4049/Jimmunol.173.8.5130 |
0.67 |
|
| 2004 |
Gehring AJ, Dobos KM, Belisle JT, Harding CV, Boom WH. Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. Journal of Immunology (Baltimore, Md. : 1950). 173: 2660-8. PMID 15294983 DOI: 10.4049/Jimmunol.173.4.2660 |
0.748 |
|
| 2004 |
Tobian AA, Canaday DH, Boom WH, Harding CV. Bacterial heat shock proteins promote CD91-dependent class I MHC cross-presentation of chaperoned peptide to CD8+ T cells by cytosolic mechanisms in dendritic cells versus vacuolar mechanisms in macrophages. Journal of Immunology (Baltimore, Md. : 1950). 172: 5277-86. PMID 15100266 DOI: 10.4049/Jimmunol.172.9.5277 |
0.653 |
|
| 2004 |
Fulton SA, Reba SM, Pai RK, Pennini M, Torres M, Harding CV, Boom WH. Inhibition of major histocompatibility complex II expression and antigen processing in murine alveolar macrophages by Mycobacterium bovis BCG and the 19-kilodalton mycobacterial lipoprotein. Infection and Immunity. 72: 2101-10. PMID 15039332 DOI: 10.1128/Iai.72.4.2101-2110.2004 |
0.688 |
|
| 2004 |
Salkowitz JR, Sieg SF, Harding CV, Lederman MM. In vitro human memory CD8 T cell expansion in response to cytomegalovirus requires CD4+ T cell help. The Journal of Infectious Diseases. 189: 971-83. PMID 14999599 DOI: 10.1086/382032 |
0.402 |
|
| 2003 |
Canaday DH, Gehring A, Leonard EG, Eilertson B, Schreiber JR, Harding CV, Boom WH. T-cell hybridomas from HLA-transgenic mice as tools for analysis of human antigen processing. Journal of Immunological Methods. 281: 129-42. PMID 14580887 DOI: 10.1016/J.Jim.2003.07.004 |
0.706 |
|
| 2003 |
von Delwig A, Ramachandra L, Harding CV, Robinson JH. Localization of peptide/MHC class II complexes in macrophages following antigen processing of viable Streptococcus pyogenes. European Journal of Immunology. 33: 2353-60. PMID 12938211 DOI: 10.1002/Eji.200323559 |
0.407 |
|
| 2003 |
Kuchtey J, Pennini M, Pai RK, Harding CV. CpG DNA induces a class II transactivator-independent increase in class II MHC by stabilizing class II MHC mRNA in B lymphocytes. Journal of Immunology (Baltimore, Md. : 1950). 171: 2320-5. PMID 12928377 DOI: 10.4049/Jimmunol.171.5.2320 |
0.637 |
|
| 2003 |
Gehring AJ, Rojas RE, Canaday DH, Lakey DL, Harding CV, Boom WH. The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2. Infection and Immunity. 71: 4487-97. PMID 12874328 DOI: 10.1128/Iai.71.8.4487-4497.2003 |
0.736 |
|
| 2003 |
Tobian AA, Potter NS, Ramachandra L, Pai RK, Convery M, Boom WH, Harding CV. Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide. Journal of Immunology (Baltimore, Md. : 1950). 171: 1413-22. PMID 12874233 DOI: 10.4049/Jimmunol.171.3.1413 |
0.836 |
|
| 2003 |
Leonard EG, Canaday DH, Harding CV, Schreiber JR. Antigen processing of the heptavalent pneumococcal conjugate vaccine carrier protein CRM(197) differs depending on the serotype of the attached polysaccharide. Infection and Immunity. 71: 4186-9. PMID 12819115 DOI: 10.1128/Iai.71.7.4186-4189.2003 |
0.36 |
|
| 2003 |
Pai RK, Convery M, Hamilton TA, Boom WH, Harding CV. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion. Journal of Immunology (Baltimore, Md. : 1950). 171: 175-84. PMID 12816996 DOI: 10.4049/Jimmunol.171.1.175 |
0.655 |
|
| 2003 |
Chefalo PJ, Grandea AG, Van Kaer L, Harding CV. Tapasin-/- and TAP1-/- macrophages are deficient in vacuolar alternate class I MHC (MHC-I) processing due to decreased MHC-I stability at phagolysosomal pH. Journal of Immunology (Baltimore, Md. : 1950). 170: 5825-33. PMID 12794107 DOI: 10.4049/Jimmunol.170.12.5825 |
0.484 |
|
| 2003 |
Harding CV, Ramachandra L, Wick MJ. Interaction of bacteria with antigen presenting cells: influences on antigen presentation and antibacterial immunity. Current Opinion in Immunology. 15: 112-9. PMID 12495742 DOI: 10.1016/S0952-7915(02)00008-0 |
0.483 |
|
| 2002 |
Canaday DH, Beigi R, Silver RF, Harding CV, Boom WH, Dubyak GR. ATP and control of intracellular growth of mycobacteria by T cells. Infection and Immunity. 70: 6456-9. PMID 12379727 DOI: 10.1128/Iai.70.11.6456-6459.2002 |
0.377 |
|
| 2002 |
Askew D, Harding CV. Differences in antigen processing with haplotype-mismatched MHC class II heterodimers: Aalpha(d)Abeta(b) heterodimers participate in early endosomal processing. European Journal of Immunology. 32: 2726-36. PMID 12355424 DOI: 10.1002/1521-4141(2002010)32:10<2726::Aid-Immu2726>3.0.Co;2-8 |
0.344 |
|
| 2002 |
Pai RK, Askew D, Boom WH, Harding CV. Regulation of class II MHC expression in APCs: roles of types I, III, and IV class II transactivator. Journal of Immunology (Baltimore, Md. : 1950). 169: 1326-33. PMID 12133955 DOI: 10.4049/Jimmunol.169.3.1326 |
0.583 |
|
| 2002 |
Rojas RE, Torres M, Fournié JJ, Harding CV, Boom WH. Phosphoantigen presentation by macrophages to mycobacterium tuberculosis--reactive Vgamma9Vdelta2+ T cells: modulation by chloroquine. Infection and Immunity. 70: 4019-27. PMID 12117907 DOI: 10.1128/Iai.70.8.4019-4027.2002 |
0.464 |
|
| 2001 |
Harding CV. Presenting exogenous antigen to T cells Current Protocols in Immunology / Edited by John E. Coligan ... [Et Al.]. PMID 18432741 DOI: 10.1002/0471142735.Im1602S23 |
0.428 |
|
| 2001 |
Harding CV, Canaday D, Ramachandra L. UNIT 16.1 Choosing and Preparing Antigen-Presenting Cells Current Protocols in Immunology. PMID 18432740 DOI: 10.1002/0471142735.Im1601S23 |
0.443 |
|
| 2001 |
Ramachandra L, Noss E, Boom WH, Harding CV. Processing of Mycobacterium tuberculosis antigen 85B involves intraphagosomal formation of peptide-major histocompatibility complex II complexes and is inhibited by live bacilli that decrease phagosome maturation. The Journal of Experimental Medicine. 194: 1421-32. PMID 11714749 DOI: 10.1084/Jem.194.10.1421 |
0.791 |
|
| 2001 |
Brinker KG, Martin E, Borron P, Mostaghel E, Doyle C, Harding CV, Wright JR. Surfactant protein D enhances bacterial antigen presentation by bone marrow-derived dendritic cells. American Journal of Physiology. Lung Cellular and Molecular Physiology. 281: L1453-63. PMID 11704542 DOI: 10.1152/Ajplung.2001.281.6.L1453 |
0.387 |
|
| 2001 |
Sieg SF, Bazdar DA, Harding CV, Lederman MM. Differential expression of interleukin-2 and gamma interferon in human immunodeficiency virus disease. Journal of Virology. 75: 9983-5. PMID 11559831 DOI: 10.1128/Jvi.75.20.9983-9985.2001 |
0.384 |
|
| 2001 |
Sieg SF, Harding CV, Lederman MM. HIV-1 infection impairs cell cycle progression of CD4(+) T cells without affecting early activation responses. The Journal of Clinical Investigation. 108: 757-64. PMID 11544282 DOI: 10.1172/Jci12685 |
0.391 |
|
| 2001 |
Canaday DH, Wilkinson RJ, Li Q, Harding CV, Silver RF, Boom WH. CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism. Journal of Immunology (Baltimore, Md. : 1950). 167: 2734-42. PMID 11509617 DOI: 10.4049/Jimmunol.167.5.2734 |
0.388 |
|
| 2001 |
Potter NS, Harding CV. Neutrophils process exogenous bacteria via an alternate class I MHC processing pathway for presentation of peptides to T lymphocytes. Journal of Immunology (Baltimore, Md. : 1950). 167: 2538-46. PMID 11509593 DOI: 10.4049/Jimmunol.167.5.2538 |
0.766 |
|
| 2001 |
Neufert C, Pai RK, Noss EH, Berger M, Boom WH, Harding CV. Mycobacterium tuberculosis 19-kDa lipoprotein promotes neutrophil activation. Journal of Immunology (Baltimore, Md. : 1950). 167: 1542-9. PMID 11466375 DOI: 10.4049/Jimmunol.167.3.1542 |
0.752 |
|
| 2001 |
Chefalo PJ, Harding CV. Processing of exogenous antigens for presentation by class I MHC molecules involves post-Golgi peptide exchange influenced by peptide-MHC complex stability and acidic pH. Journal of Immunology (Baltimore, Md. : 1950). 167: 1274-82. PMID 11466343 DOI: 10.4049/Jimmunol.167.3.1274 |
0.377 |
|
| 2001 |
Noss EH, Pai RK, Sellati TJ, Radolf JD, Belisle J, Golenbock DT, Boom WH, Harding CV. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. Journal of Immunology (Baltimore, Md. : 1950). 167: 910-8. PMID 11441098 DOI: 10.4049/Jimmunol.167.2.910 |
0.812 |
|
| 2001 |
Ramachandra L, Noss E, Boom WH, Harding CV. Phagocytic processing of antigens for presentation by class II major histocompatibility complex molecules. Cellular Microbiology. 1: 205-14. PMID 11207553 DOI: 10.1046/J.1462-5822.1999.00026.X |
0.777 |
|
| 2001 |
Askew D, Chu RS, Krieg AM, Harding CV. CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms. Journal of Immunology (Baltimore, Md. : 1950). 165: 6889-95. PMID 11120813 DOI: 10.4049/Jimmunol.165.12.6889 |
0.509 |
|
| 2000 |
Noss EH, Harding CV, Boom WH. Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages. Cellular Immunology. 201: 63-74. PMID 10805975 DOI: 10.1006/Cimm.2000.1633 |
0.782 |
|
| 2000 |
Ramachandra L, Harding CV. Phagosomes acquire nascent and recycling class II MHC molecules but primarily use nascent molecules in phagocytic antigen processing. Journal of Immunology (Baltimore, Md. : 1950). 164: 5103-12. PMID 10799867 DOI: 10.4049/Jimmunol.164.10.5103 |
0.503 |
|
| 2000 |
Song R, Porgador A, Harding CV. Peptide-receptive class I major histocompatibility complex molecules on TAP-deficient and wild-type cells and their roles in the processing of exogenous antigens. Immunology. 97: 316-24. PMID 10447748 DOI: 10.1046/J.1365-2567.1999.00759.X |
0.461 |
|
| 1999 |
McCool TL, Harding CV, Greenspan NS, Schreiber JR. B- and T-cell immune responses to pneumococcal conjugate vaccines: divergence between carrier- and polysaccharide-specific immunogenicity. Infection and Immunity. 67: 4862-9. PMID 10456942 DOI: 10.1128/Iai.67.9.4862-4869.1999 |
0.395 |
|
| 1999 |
Chu RS, Askew D, Noss EH, Tobian A, Krieg AM, Harding CV. CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing. Journal of Immunology (Baltimore, Md. : 1950). 163: 1188-94. PMID 10415013 |
0.802 |
|
| 1999 |
Ramachandra L, Chu RS, Askew D, Noss EH, Canaday DH, Potter NS, Johnsen A, Krieg AM, Nedrud JG, Boom WH, Harding CV. Phagocytic antigen processing and effects of microbial products on antigen processing and T-cell responses. Immunological Reviews. 168: 217-39. PMID 10399077 DOI: 10.1111/J.1600-065X.1999.Tb01295.X |
0.809 |
|
| 1999 |
Canaday DH, Ziebold C, Noss EH, Chervenak KA, Harding CV, Boom WH. Activation of human CD8+ alpha beta TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway. Journal of Immunology (Baltimore, Md. : 1950). 162: 372-9. PMID 9886409 |
0.755 |
|
| 1998 |
Ramachandra L, Sramkoski RM, Canaday DH, Boom WH, Harding CV. Flow analysis of MHC molecules and other membrane proteins in isolated phagosomes. Journal of Immunological Methods. 213: 53-71. PMID 9671125 DOI: 10.1016/S0022-1759(98)00017-9 |
0.354 |
|
| 1998 |
Matousek MP, Nedrud JG, Cieplak W, Harding CV. Inhibition of Class II Major Histocompatibility Complex Antigen Processing by Escherichia coli Heat-Labile Enterotoxin Requires an Enzymatically Active A Subunit Infection and Immunity. 66: 3480-3484. DOI: 10.1128/Iai.66.7.3480-3484.1998 |
0.439 |
|
| 1997 |
Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. The Journal of Experimental Medicine. 186: 1623-31. PMID 9362523 DOI: 10.1084/Jem.186.10.1623 |
0.364 |
|
| 1997 |
Oh YK, Harding CV, Swanson JA. The efficiency of antigen delivery from macrophage phagosomes into cytoplasm for MHC class I-restricted antigen presentation. Vaccine. 15: 511-8. PMID 9160518 DOI: 10.1016/S0264-410X(97)00221-1 |
0.467 |
|
| 1996 |
Harding CV. Class II antigen processing: Analysis of compartments and functions Critical Reviews in Immunology. 16: 13-29. PMID 8809471 DOI: 10.1615/Critrevimmunol.V16.I1.20 |
0.494 |
|
| 1996 |
Hockett RD, Cook JR, Findlay K, Harding CV. Interferon-γ differentially regulates antigen-processing functions in distinct endocytic compartments of macrophages with constitutive expression of class II major histocompatibility complex molecules Immunology. 88: 68-75. PMID 8707353 DOI: 10.1046/J.1365-2567.1996.D01-632.X |
0.509 |
|
| 1996 |
Harding CV. Class I MHC presentation of exogenous antigens Journal of Clinical Immunology. 16: 90-96. PMID 8690777 DOI: 10.1007/Bf01540955 |
0.513 |
|
| 1996 |
Raposo G, Nijman HW, Stoorvogel W, Leijendekker R, Harding CV, Melief CJM, Geuze HJ. B lymphocytes secrete antigen-presenting vesicles Journal of Experimental Medicine. 183: 1161-1172. PMID 8642258 DOI: 10.1084/jem.183.3.1161 |
0.342 |
|
| 1995 |
Harding CV. Intracellular organelles involved in antigen processing and the binding of peptides to class II MHC molecules Seminars in Immunology. 7: 355-360. PMID 8775461 DOI: 10.1006/Smim.1995.0040 |
0.501 |
|
| 1995 |
Wick MJ, Harding CV, Twesten NJ, Normark SJ, Pfeifer JD. The phoP locus influences processing and presentation of Salmonella typhimurium antigens by activated macrophages. Molecular Microbiology. 16: 465-76. PMID 7565107 DOI: 10.1111/J.1365-2958.1995.Tb02411.X |
0.463 |
|
| 1995 |
Harding CV. Phagocytic processing of antigens for presentation by MHC molecules Trends in Cell Biology. 5: 105-109. DOI: 10.1016/S0962-8924(00)88959-X |
0.472 |
|
| 1994 |
Harding CV, Geuze HJ. Antigen processing and intracellular traffic of antigens and MHC molecules. Current Opinion in Cell Biology. 5: 596-605. PMID 8257600 DOI: 10.1016/0955-0674(93)90128-D |
0.48 |
|
| 1994 |
Harding CV. Techniques for studying phagocytic processing of bacteria for class I or II MHC-restricted antigen recognition by T lymphocytes Methods in Cell Biology. 45: 313-326. PMID 7707994 DOI: 10.1016/S0091-679X(08)61859-2 |
0.521 |
|
| 1993 |
Harding CV. Cellular and molecular aspects of antigen processing and the function of class II MHC molecules American Journal of Respiratory Cell and Molecular Biology. 8: 461-467. PMID 8481229 DOI: 10.1165/Ajrcmb/8.5.461 |
0.5 |
|
| 1993 |
Pfeifer JD, Wick MJ, Roberts RL, Findlay K, Normark SJ, Harding CV. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature. 361: 359-62. PMID 7678924 DOI: 10.1038/361359A0 |
0.525 |
|
| 1993 |
Nelson CA, Harding CV, Unanue ER. Biochemical anatomy of antigen processing. Cold Spring Harbor Symposia On Quantitative Biology. 57: 557-63. PMID 1339693 DOI: 10.1101/Sqb.1992.057.01.061 |
0.38 |
|
| 1993 |
Wick MJ, Pfeifer JD, Findlay KA, Harding CV, Normark SJ. Compartmentalization of defined epitopes expressed in Escherichia coli has only a minor influence on efficiency of phagocytic processing for presentation by class I and class II major histocompatibility complex molecules to T cells. Infection and Immunity. 61: 4848-4856. DOI: 10.1128/iai.61.11.4848-4856.1993 |
0.383 |
|
| 1992 |
Harding CV. Electroporation of exogenous antigen into the cytosol for antigen processing and class I major histocompatibility complex (MHC) presentation: weak base amines and hypothermia (18 degrees C) inhibit the class I MHC processing pathway. European Journal of Immunology. 22: 1865-9. PMID 1623927 DOI: 10.1002/Eji.1830220728 |
0.484 |
|
| 1992 |
Harding CV, Collins D, Unanue ER. Processing of liposome-encapsulated antigens targeted to specific subcellular compartments. Research in Immunology. 143: 188-91. PMID 1574645 DOI: 10.1016/S0923-2494(92)80163-F |
0.352 |
|
| 1992 |
De Bruijn MLH, Nieland JD, Harding CV, Melief CJM. Processing and presentation of intact hen egg-white lysozyme by dendritic cells European Journal of Immunology. 22: 2347-2352. PMID 1516625 DOI: 10.1002/Eji.1830220925 |
0.389 |
|
| 1992 |
Harding CV, Geuze HJ. Class II MHC molecules are present in macrophage lysosomes and phagolysosomes that function in the phagocytic processing of Listeria monocytogenes for presentation to T cells. The Journal of Cell Biology. 119: 531-42. PMID 1400590 DOI: 10.1083/Jcb.119.3.531 |
0.537 |
|
| 1991 |
Harding CV, Unanue ER. Cellular mechanisms of antigen processing and the function of class I and II major histocompatibility complex molecules. Cell Regulation. 1: 499-509. PMID 2098113 DOI: 10.1091/Mbc.1.7.499 |
0.448 |
|
| 1991 |
Harding CV. Pathways of antigen processing Current Opinion in Immunology. 3: 3-9. PMID 2054112 DOI: 10.1016/0952-7915(91)90068-C |
0.438 |
|
| 1991 |
Harding CV, Roof RW, Allen PM, Unanue ER. Effects of pH and polysaccharides on peptide binding to class II major histocompatibility complex molecules. Proceedings of the National Academy of Sciences of the United States of America. 88: 2740-4. PMID 2011583 DOI: 10.1073/Pnas.88.7.2740 |
0.343 |
|
| 1991 |
Harding CV, Collins DS, Slot JW, Geuze HJ, Unanue ER. Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells. Cell. 64: 393-401. PMID 1899049 DOI: 10.1016/0092-8674(91)90647-H |
0.483 |
|
| 1990 |
Unanue ER, Harding CV, Luescher IF, Roof RW. Antigen-binding function of class II MHC molecules. Cold Spring Harbor Symposia On Quantitative Biology. 383-92. PMID 2639760 DOI: 10.1101/Sqb.1989.054.01.047 |
0.421 |
|
| 1990 |
Harding CV, Unanue ER, Slot JW, Schwartz AL, Geuze HJ. Functional and ultrastructural evidence for intracellular formation of major histocompatibility complex class II-peptide complexes during antigen processing. Proceedings of the National Academy of Sciences of the United States of America. 87: 5553-7. PMID 2371288 DOI: 10.1073/pnas.87.14.5553 |
0.394 |
|
| 1990 |
Harding CV, Unanue ER. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation Nature. 346: 574-576. PMID 2115981 DOI: 10.1038/346574A0 |
0.493 |
|
| 1990 |
Harding CV, Unanue ER. Low-temperature inhibition of antigen processing and iron uptake from transferrin: Deficits in endosome functions at 18°C European Journal of Immunology. 20: 323-329. PMID 1968838 DOI: 10.1002/Eji.1830200214 |
0.452 |
|
| 1989 |
Harding CV, Leyva-Cobian F, Unanue ER. Mechanisms of antigen processing. Immunological Reviews. 106: 77-92. PMID 3075593 DOI: 10.1111/J.1600-065X.1988.Tb00774.X |
0.473 |
|
| 1989 |
Harding CV, Roof RW, Unanue ER. Turnover of Ia-peptide complexes is facilitated in viable antigen-presenting cells: biosynthetic turnover of Ia vs. peptide exchange. Proceedings of the National Academy of Sciences of the United States of America. 86: 4230-4. PMID 2786208 DOI: 10.1073/Pnas.86.11.4230 |
0.429 |
|
| 1983 |
Harding C, Stahl P. Transferrin recycling in reticulocytes: pH and iron are important determinants of ligand binding and processing Biochemical and Biophysical Research Communications. 113: 650-658. PMID 6870878 DOI: 10.1016/0006-291X(83)91776-X |
0.503 |
|
| 1983 |
Harding C, Heuser J, Stahl P. Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. The Journal of Cell Biology. 97: 329-39. PMID 6309857 DOI: 10.1083/Jcb.97.2.329 |
0.583 |
|
| Show low-probability matches. |